|Products||VerifyNow Aspirin Assay|
|Item||VerifyNow Aspirin Assay|
|Features|| Each single-use disposable assay device, such as the VerifyNow IIb/IIIa or VerifyNow Aspirin Assay, contains all needed reagents to provide analytical results for a specific assay. Assay devices are individually pouched and may be used until the expiration date printed on each kit box and foil pouch.
The assay device consists of the following components:
|Description|| Aspirin is the medication most commonly prescribed for the prevention of life threatening vascular events such as heart attacks and strokes. However, a number of studies have shown that as many as 30% of people taking daily aspirin therapy to prevent a recurrent vascular event may not be receiving aspirin's full benefits. These people are at greater risk for a heart attack or stroke.|
The VerifyNow Aspirin Assay is a qualitative test to aid in the detection of platelet dysfunction due to aspirin (ASA) ingestion in citrated whole blood for the point of care or laboratory setting.
The VerifyNow System is a turbidimetric based optical detection system which measures platelet induced aggregation as an increase in light transmittance. The system consists of an instrument, a disposable assay device and controls. The assay device contains reagents based on microbead agglutination technology. The assay device contains a lyophilized preparation of human fibrinogen-coated beads, platelet agonist, preservative and buffer. The patient sample is 3.2% citrated whole blood, which is automatically dispensed from the blood collection tube into the assay device by the instrument, with no blood handling required by the user.
|Info|| Accumetrics |
Customer Service: (800) 643-1640
Web site: http://www.accumetrics.com